Position in TGTX
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$13,791,313
+$5,518,703 QoQ
Shares Held
251,025
+0.8% QoQ
Ownership
0.164%
of shares outstanding
% of Portfolio
9.01%
of 13F equity value
Holder Rank
#61
of 425 holders
Holding Since
Jun 2021
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ACT CAPITAL MANAGEMENT, LLC holds $97,112,758 across 27 Biotechnology names. TGTX ranks #2 (14.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KRYS |
Krystal Biotech, Inc.
|
45,000 | $16,725,150 | |
| 2 | TGTX |
Tg Therapeutics, Inc.
This page
|
251,025 | $13,791,313 | |
| 3 | ABVX |
Abivax S.A.
|
97,000 | $12,926,220 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
110,100 | $8,974,251 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
209,300 | $8,164,793 | |
| 6 | CELC |
Celcuity Inc.
|
62,150 | $6,502,133 | |
| 7 | NKTR |
Nektar Therapeutics
|
89,300 | $6,234,033 | |
| 8 | CYTK |
Cytokinetics Inc
|
47,500 | $4,046,525 |
All Filings in TGTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,791,313 | 251,025 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $8,272,610 | 249,025 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $8,015,163 | 268,875 | Shares | Sole | 2026-02-17 | |
| 2021-12-31 | $644,100 | 33,900 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $1,996,800 | 60,000 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $2,133,450 | 55,000 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||